相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes
Sangeeta R. Kashyap et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism
Joan Domingo-Espin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Inhalation of peptide-loaded nanoparticles improves heart failure
Michele Miragoli et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
M. Angelyn Bethel et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
Juraj Koska et al.
DIABETES CARE (2018)
High-density lipoprotein delivered after myocardial infarction increases cardiac glucose uptake and function in mice
Sarah E. Heywood et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A Mendelian Randomization Study of Metabolite Profiles, Fasting Glucose, and Type 2 Diabetes
Jun Liu et al.
DIABETES (2017)
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S. Rosenson et al.
NATURE REVIEWS CARDIOLOGY (2016)
Dual Actions of Apolipoprotein A-I on Glucose-Stimulated Insulin Secretion and Insulin-Independent Peripheral Tissue Glucose Uptake Lead to Increased Heart and Skeletal Muscle Glucose Disposal
Joan Domingo-Espin et al.
DIABETES (2016)
In vivo PET imaging with [18F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes
Blake J. Cochran et al.
DIABETOLOGIA (2016)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohammad H. Forouzanfar et al.
LANCET (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
HDL and glucose metabolism: current evidence and therapeutic potential
Andrew L. Siebel et al.
FRONTIERS IN PHARMACOLOGY (2015)
Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant
Jonathan Dalla-Riva et al.
PLOS ONE (2015)
Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice
Karin G. Stenkula et al.
DIABETOLOGIA (2014)
Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility
Jitka Petrlova et al.
PLOS ONE (2014)
High-Density Lipoprotein Maintains Skeletal Muscle Function by Modulating Cellular Respiration in Mice
Maarit Lehti et al.
CIRCULATION (2013)
The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE-/- mouse model
Tracey Gaspari et al.
DIABETES & VASCULAR DISEASE RESEARCH (2013)
Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle
Jonathan Dalla-Riva et al.
JOURNAL OF LIPID RESEARCH (2013)
High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
Brian G. Drew et al.
CIRCULATION (2009)
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Ralph A. DeFronzo et al.
DIABETES CARE (2009)
The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice
Stephen J. Peterson et al.
JOURNAL OF LIPID RESEARCH (2009)
L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice
Stephen J. Peterson et al.
JOURNAL OF LIPID RESEARCH (2008)
Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism
R. Han et al.
DIABETOLOGIA (2007)
Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties
A. Hoang et al.
DIABETOLOGIA (2007)
Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids
C Vedhachalam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
分享论文
